📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo. (2020)

First Author: Read C

Attributed to: Cambridge Confidence in Concepts: translating pathophysiological insights for patient benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2020.588669

PubMed Identifier: 33716722

Publication URI: http://europepmc.org/abstract/MED/33716722

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812